ST. LOUIS, June 02, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced it has reached a significant milestone of over 400 scientific publications now documenting the clinical benefits of Stereotaxis robotic technology. A complete, searchable database of all publications is available online at http://www.RoboticEP.com/Clinical-Data Continue reading →

Coala Life, a Swedish innovator in remote cardiac and respiratory monitoring, has launched the first smartphone powered virtual cardiac and respiratory diagnostics solution with real-time, p-wave based detection of nine common arrhythmias. The Coala is also powered by algorithms that enables physicians to remotely detect murmurs and auscultate heart and lungs during in patients daily life. Continue reading →

Adrian Hernandez was named vice dean and executive director of the Duke Clinical Research Institute last month. After a national search, the Duke University School of Medicine named Adrian Hernandez vice dean and executive director of the Duke Clinical Research Institute last month. In the new position, Hernandez oversees DCRIs research and teaching agenda, ensuring the Institute sustains a broad spectrum of clinical research programs and trials. Continue reading →

As the rigor of COVID-19 research comes under increasing scrutiny, a deep dive into contemporary trials of invasive cardiovascular interventions finds intricate ties with industry and the art of spin on full display. After examining 216 randomized controlled trials published in the past decade, researchers found that more than half (53.2%) were commercially funded. In 18.3% of these trials, the sponsor was involved with the trial conduct and reporting Continue reading →

Still taking a daily aspirin to ward off heart attacks? You might want to think again, according to a new review Continue reading →